Following 3 questions are related with the text below: GE Healthcare Systems has uncovered that midwives in Indonesia were frustrated that they lacked tools to understand risks in pregnancies. Indonesia, the fourth most populous country with around 250 million people, was chosen to serve as the primary market for Omega device. Indonesia had a rate of 20 new births for every 1000 people in 2010, and midwives played a significant part in these births. A recent study had highlighted the important role of midwives, and indicated their easier accessibility, with 25 mid-wives for every 100,000 people. Midwives were also lower cost option, and the Jakarta Post detailed a typical case in 2008, where a woman who was charged US $45 for a midwife-assisted birth, whereas a hospital may charge ten times that amount for a doctor. The Omega product concept required an investment of $10 million and was positioned as an easy-to-use, affordable Ultrasound system for scanning pregnant women, targeted specifically at midwives and nurses in Indonesia. Problems could be identified early and then women with potential complications could be referred for further medical attention. The expected price was around $4,000 and the team proposed to demonstrate the product via pilot tests. They use margin multiplier of 2. GE estimated that 1 or 2 out of every 4 midwives in Indonesia would be able to afford the device and have an economically feasible reason to purchase the device but given the novelty of the product in this setting, there was significant uncertainty in achieving sales targets. There were 5 million births per year in Indonesia assisted by midwives.